GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » U-Neuron Biomedical Inc (ROCO:6973) » Definitions » EV-to-Revenue

U-Neuron Biomedical (ROCO:6973) EV-to-Revenue : 35.78 (As of May. 26, 2024)


View and export this data going back to 2023. Start your Free Trial

What is U-Neuron Biomedical EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, U-Neuron Biomedical's enterprise value is NT$966.88 Mil. U-Neuron Biomedical's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was NT$27.02 Mil. Therefore, U-Neuron Biomedical's EV-to-Revenue for today is 35.78.

The historical rank and industry rank for U-Neuron Biomedical's EV-to-Revenue or its related term are showing as below:

ROCO:6973' s EV-to-Revenue Range Over the Past 10 Years
Min: 25.64   Med: 30.51   Max: 34.82
Current: 35.78

During the past 4 years, the highest EV-to-Revenue of U-Neuron Biomedical was 34.82. The lowest was 25.64. And the median was 30.51.

ROCO:6973's EV-to-Revenue is ranked worse than
73.82% of 1039 companies
in the Biotechnology industry
Industry Median: 8.18 vs ROCO:6973: 35.78

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-26), U-Neuron Biomedical's stock price is NT$48.50. U-Neuron Biomedical's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was NT$0.91. Therefore, U-Neuron Biomedical's PS Ratio for today is 53.06.

U-Neuron Biomedical EV-to-Revenue Historical Data

The historical data trend for U-Neuron Biomedical's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

U-Neuron Biomedical EV-to-Revenue Chart

U-Neuron Biomedical Annual Data
Trend Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
- - - 48.36

U-Neuron Biomedical Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-Revenue - - - - 48.36

Competitive Comparison of U-Neuron Biomedical's EV-to-Revenue

For the Biotechnology subindustry, U-Neuron Biomedical's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

U-Neuron Biomedical's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, U-Neuron Biomedical's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where U-Neuron Biomedical's EV-to-Revenue falls into.


U-Neuron Biomedical EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

U-Neuron Biomedical's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=966.881/27.023
=35.78

U-Neuron Biomedical's current Enterprise Value is NT$966.88 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. U-Neuron Biomedical's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was NT$27.02 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

U-Neuron Biomedical  (ROCO:6973) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

U-Neuron Biomedical's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=48.50/0.914
=53.06

U-Neuron Biomedical's share price for today is NT$48.50.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2023 was NT$0.91.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

U-Neuron Biomedical EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of U-Neuron Biomedical's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

U-Neuron Biomedical (ROCO:6973) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » U-Neuron Biomedical Inc (ROCO:6973) » Definitions » EV-to-Revenue
Comparable Companies
Traded in Other Exchanges
N/A
Address
Website
https://en.u-neuron.com
U-Neuron Biomedical Inc is engaged in research and development of stem cell storage & separation technology, and treatment application technology. It has patent on the Technology of Culture and Isolation of Amniotic Fluid Stem Cell.

U-Neuron Biomedical (ROCO:6973) Headlines

No Headlines